Literature DB >> 22695068

Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope.

Jai S Rudra1, Satish Mishra, Anita S Chong, Robert A Mitchell, Elizabeth H Nardin, Victor Nussenzweig, Joel H Collier.   

Abstract

Biomaterials that modulate innate and adaptive immune responses are receiving increasing interest as adjuvants for eliciting protective immunity against a variety of diseases. Previous results have indicated that self-assembling β-sheet peptides, when fused with short peptide epitopes, can act as effective adjuvants and elicit robust and long-lived antibody responses. Here we investigated the mechanism of immunogenicity and the quality of antibody responses raised by a peptide epitope from Plasmodium falciparum circumsporozoite (CS) protein, (NANP)(3),conjugated to the self-assembling peptide domain Q11. The mechanism of adjuvant action was investigated in knockout mice with impaired MyD88, NALP3, TLR-2, or TLR-5 function, and the quality of antibodies raised against (NANP)(3)-Q11 was assessed using a transgenic sporozoite neutralizing (TSN) assay for malaria infection. (NANP)(3)-Q11 self-assembled into nanofibers, and antibody responses lasted up to 40 weeks in C57BL/6 mice. The antibody responses were T cell- and MyD88-dependent. Sera from mice primed with either irradiated sporozoites or a synthetic peptide, (T1BT*)(4)-P3C, and boosted with (NANP)(3)-Q11 showed significant increases in antibody titers and significant inhibition of sporozoite infection in TSN assays. In addition, two different epitopes could be self-assembled together without compromising the strength or duration of the antibody responses raised against either of them, making these materials promising platforms for self-adjuvanting multi-antigenic immunotherapies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695068      PMCID: PMC3392361          DOI: 10.1016/j.biomaterials.2012.05.041

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  59 in total

1.  A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies.

Authors:  J A López; C Weilenman; R Audran; M A Roggero; A Bonelo; J M Tiercy; F Spertini; G Corradin
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

Review 2.  Designing polymeric particles for antigen delivery.

Authors:  Stefaan De Koker; Bart N Lambrecht; Monique A Willart; Yvette van Kooyk; Johan Grooten; Chris Vervaet; Jean Paul Remon; Bruno G De Geest
Journal:  Chem Soc Rev       Date:  2010-11-09       Impact factor: 54.564

Review 3.  More than one reason to rethink the use of peptides in vaccine design.

Authors:  Anthony W Purcell; James McCluskey; Jamie Rossjohn
Journal:  Nat Rev Drug Discov       Date:  2007-05       Impact factor: 84.694

Review 4.  The path to a successful vaccine adjuvant--'the long and winding road'.

Authors:  Derek T O'Hagan; Ennio De Gregorio
Journal:  Drug Discov Today       Date:  2009-03-05       Impact factor: 7.851

5.  Toll-like receptors 1 and 2 cooperatively mediate immune responses to curli, a common amyloid from enterobacterial biofilms.

Authors:  Cagla Tükel; Jessalyn H Nishimori; R Paul Wilson; Maria G Winter; A Marijke Keestra; Jos P M van Putten; Andreas J Bäumler
Journal:  Cell Microbiol       Date:  2010-10       Impact factor: 3.715

6.  A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.

Authors:  E H Nardin; J M Calvo-Calle; G A Oliveira; R S Nussenzweig; M Schneider; J M Tiercy; L Loutan; D Hochstrasser; K Rose
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

7.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

8.  Multifactorial optimization of endothelial cell growth using modular synthetic extracellular matrices.

Authors:  Jangwook P Jung; José V Moyano; Joel H Collier
Journal:  Integr Biol (Camb)       Date:  2011-01-19       Impact factor: 2.192

Review 9.  Vaccine adjuvants: putting innate immunity to work.

Authors:  Robert L Coffman; Alan Sher; Robert A Seder
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

10.  Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.

Authors:  M F Good; J A Berzofsky; W L Maloy; Y Hayashi; N Fujii; W T Hockmeyer; L H Miller
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  60 in total

Review 1.  Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials.

Authors:  Xuewen Du; Jie Zhou; Junfeng Shi; Bing Xu
Journal:  Chem Rev       Date:  2015-12-08       Impact factor: 60.622

Review 2.  Hydrogels and scaffolds for immunomodulation.

Authors:  Ankur Singh; Nicholas A Peppas
Journal:  Adv Mater       Date:  2014-08-25       Impact factor: 30.849

Review 3.  Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Authors:  Fazren Azmi; Abdullah Al Hadi Ahmad Fuaad; Mariusz Skwarczynski; Istvan Toth
Journal:  Hum Vaccin Immunother       Date:  2013-12-03       Impact factor: 3.452

4.  MyD88 in antigen-presenting cells is not required for CD4+ T-cell responses during peptide nanofiber vaccination.

Authors:  Youhui Si; Yi Wen; Jianjun Chen; Rebecca R Pompano; Huifang Han; Joel Collier; Anita S Chong
Journal:  Medchemcomm       Date:  2017-11-29       Impact factor: 3.597

5.  A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers.

Authors:  Yaoying Wu; Pamela K Norberg; Elizabeth A Reap; Kendra L Congdon; Chelsea N Fries; Sean H Kelly; John H Sampson; Vincent P Conticello; Joel H Collier
Journal:  ACS Biomater Sci Eng       Date:  2017-09-11

6.  A self-adjuvanting supramolecular vaccine carrying a folded protein antigen.

Authors:  Gregory A Hudalla; Justin A Modica; Ye F Tian; Jai S Rudra; Anita S Chong; Tao Sun; Milan Mrksich; Joel H Collier
Journal:  Adv Healthc Mater       Date:  2013-02-25       Impact factor: 9.933

Review 7.  Supramolecular biofunctional materials.

Authors:  Jie Zhou; Jie Li; Xuewen Du; Bing Xu
Journal:  Biomaterials       Date:  2017-03-12       Impact factor: 12.479

8.  Suppression of Cocaine-Evoked Hyperactivity by Self-Adjuvanting and Multivalent Peptide Nanofiber Vaccines.

Authors:  Jai S Rudra; Ye Ding; Harshini Neelakantan; Chunyong Ding; Rajagopal Appavu; Sonja Stutz; Joshua D Snook; Haiying Chen; Kathryn A Cunningham; Jia Zhou
Journal:  ACS Chem Neurosci       Date:  2016-03-08       Impact factor: 4.418

Review 9.  Biologics to treat substance use disorders: Current status and new directions.

Authors:  Marco Pravetoni
Journal:  Hum Vaccin Immunother       Date:  2016-07-21       Impact factor: 3.452

Review 10.  Beyond antigens and adjuvants: formulating future vaccines.

Authors:  Tyson J Moyer; Andrew C Zmolek; Darrell J Irvine
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.